Tradestie Institutional Equity Comparison Engine
XPH vs XES โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XPH Overall Edge
XPH Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SPDR S&P Pharmaceuticals ETF (XPH) driven by superior Momentum & Technical while XES counters with relative strength in Options & Structure. Fundamentally, XPH trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus XES at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, XPH sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro) against XES sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
XPH N/M vs XES N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
XPH
1Y +30.6% vs +26.1% ยท 52W Pos 64% vs 40%
Options & Structure Winner
XES
UNCLASSIFIED (5th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
XPH
NYSE Arca
SPDR S&P Pharmaceuticals ETF
Institutional Equity
$65.58
-1.87% 1D
Market Cap
N/A
1M Return
+6.05%
1Y Return
+30.61%
Forward P/E
N/M
Unified AI Score
41.0 / 100
SELL
Tech 37.0
Fund 45.0
Flow 50.0
Mom 50.0
XES
NYSE Arca
SPDR S&P Oil & Gas Equipment & Services ETF
Institutional Equity
$98.89
-3.5% 1D
Market Cap
N/A
1M Return
-6.64%
1Y Return
+26.12%
Forward P/E
N/M
Unified AI Score
46.0 / 100
HOLD
Tech 52.0
Fund 51.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XPH +30.61%
XES +26.12%
Spread: +4.49 pp (XPH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XPH TTM Op. Margin: N/A
XES TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XPH vs XES. Trailing 12-month operating profitability (XPH N/A vs XES N/A) and valuation multiples (XPH N/M vs XES N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XPH | XES | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 64% ($50โ$74) | 40% ($75โ$135) | Stronger Trend | XPH |
| Beta / 30D Volatility Risk Regime | 0.87ฮฒ ยท 32% Vol | 0.58ฮฒ ยท 52% Vol | Lower Realized Risk | XPH |
| Unified Institutional Score Composite Signal | 41.0 / 100 (SELL) | 46.0 / 100 (HOLD) | Higher Composite | XES |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XPH vs XES Buy Guide
XPH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
XES
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XPH nor XES registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.